WHO ICTRP trial

A prospective, one arm, exploratory research study of rATG pretreatment regimen…

ChiCTR2300077547 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting

Key facts

Trial ID ChiCTR2300077547
Public title A prospective, one arm, exploratory research study of rATG pretreatment regimen in the treatment of transfusion dependent non severe aplastic anemia
Scientific title A prospective, one arm, exploratory research study of rATG pretreatment regimen in the treatment of transfusion dependent non severe aplastic anemia
Primary sponsor The First Affiliated Hospital of Henan University of Science and Technology
Registry Chinese Clinical Trial Registry (ChiCTR)
Recruitment status Recruiting
Study type Interventional study
Phase 0
Countries China
Conditions Transfusion dependent non severe aplastic anemia
Interventions Experimental group:(rATG/Bu/CTX/Flu/FK506) protocol: Rabbit anti thymocyte globulin 2.5 mg/(kg·d) (-13 days to -10 days), busulfan 3.2 mg/(kg·d) (-7 days to -6 days), cyclophosphamide 25 mg/(kg·d) (-5 days to -4 days), fludarabine 30…
Registration date Nov 13, 2023
Target size Experimental group:40
Registry page chictr.org.cn

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations